Manhattan Associates (MANH) EBITDA (2016 - 2025)
Historic EBITDA for Manhattan Associates (MANH) over the last 17 years, with Q4 2025 value amounting to $67.0 million.
- Manhattan Associates' EBITDA rose 1042.05% to $67.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $279.8 million, marking a year-over-year increase of 695.88%. This contributed to the annual value of $279.8 million for FY2025, which is 695.88% up from last year.
- Manhattan Associates' EBITDA amounted to $67.0 million in Q4 2025, which was up 1042.05% from $75.8 million recorded in Q3 2025.
- In the past 5 years, Manhattan Associates' EBITDA registered a high of $75.8 million during Q3 2025, and its lowest value of $25.4 million during Q1 2021.
- In the last 5 years, Manhattan Associates' EBITDA had a median value of $52.0 million in 2023 and averaged $51.9 million.
- Over the last 5 years, Manhattan Associates' EBITDA had its largest YoY gain of 6470.18% in 2022, and its largest YoY loss of 1329.47% in 2022.
- Quarter analysis of 5 years shows Manhattan Associates' EBITDA stood at $27.1 million in 2021, then surged by 64.7% to $44.7 million in 2022, then surged by 31.67% to $58.9 million in 2023, then rose by 3.1% to $60.7 million in 2024, then increased by 10.42% to $67.0 million in 2025.
- Its EBITDA was $67.0 million in Q4 2025, compared to $75.8 million in Q3 2025 and $73.8 million in Q2 2025.